Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWoodbois Regulatory News (WBI)

  • This share is currently suspended. It was suspended at a price of 0.03
  • There is currently no data for WBI

Business Update

5 Feb 2025 10:30

RNS Number : 0331W
Woodbois Limited
05 February 2025
 

This announcement is released by the Company and the information contained within this announcement is deemed by the Company to constitute inside information for the purposes of Article 7 of the UK version of the EU Market Abuse Regulation (Regulation (EU) No.596/2014) which forms part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended. Upon the publication of this announcement via a Regulatory Information Service, such information is now considered to be in the public domain. The person responsible for arranging for the release of this announcement on behalf of the Company is Paul Shackleton, Non-executive Director.

 

5 February 2025

 

WOODBOIS LIMITED

("Woodbois" or the "Company")

 

Business update

 

Following the disruption to the business last year, which saw production halt and a number of management changes, the Company is now experiencing the financial effect of this, with tight working capital and a heightened level of creditors. Once production has fully restarted we believe that the business will generate cash and we will be able to normalise payments for all creditors over a few weeks.

 

The patience of some of our creditors has understandably worn thin, exacerbated perhaps by a lack of communication in the last quarter of 2024, which we are seeking to redress; we note a court decision in Gabon in favour of BGFI Bank ("BGFI"), a Gabon based financial institution, allowing it to commence procedures to recover funds of EUR 790k owed to it by Woodbois. We believe that the best outcome for all stakeholders, including BGFI, our loyal employees in Gabon and long suffering shareholders will be achieved through production. The Company has begun to ship containers of existing stock from the port in Libreville, and is now beginning to move stock from the warehouse in Mouila to the port.

 

We are discussing with advisers financing options to bridge our working capital needed for production over the next few weeks. Further announcements will be made as appropriate.

 

Enquiries:

 

Woodbois Limited

Clive Roberts, Independent Non-executive Director

Paul Shackleton, Independent Non-executive Director

 

Allenby Capital Limited (Nominated Adviser)

John Depasquale, Piers Shimwell

 

+44 (0)20 3328 5656 info@allenbycapital.com

Novum Securities (Joint Broker)

Colin Rowbury, Jon Bellis

+44 (0) 20 7399 9427

 

Axis Capital Markets Limited (Joint Broker)

Ben Tadd, Lewis Jones

+44 (0) 203 026 0449

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDUVURRVWUURAR
Date   Source Headline
1st Apr 20191:12 pmRNSHolding(s) in Company
27th Mar 20197:00 amRNSEquity Raise and Group Restructuring Update
20th Mar 20191:20 pmRNSResults of General Meeting and Change of Name
14th Mar 20195:32 pmRNSHolding(s) in Company
13th Mar 20191:25 pmRNSHolding(s) in Company
11th Mar 20197:00 amRNSHolding(s) in Company
7th Mar 20197:00 amRNSEquity Raise
28th Feb 20197:00 amRNSNotice of General Meeting
21st Jan 20197:01 amRNSDirector/PDMR Shareholding
21st Jan 20197:00 amRNSLong Term Incentive Plan
16th Jan 20191:44 pmRNSHolding(s) in Company
14th Jan 20198:08 amRNSQuarterly Update - Replacement
14th Jan 20197:00 amRNSQuarterly Update
11th Jan 20197:00 amRNSAppointment of New Nominated Adviser and Broker
10th Jan 20197:00 amRNSGroup Reorganisation and Fundraising
21st Nov 201812:49 pmRNSUpdate re: Nominated Adviser
5th Nov 20187:00 amRNSHolding(s) in Company
2nd Nov 20183:19 pmRNSDirector/PDMR Shareholding
2nd Nov 20183:14 pmRNSTotal Voting Rights
2nd Nov 20187:00 amRNSDirector/PDMR Shareholding
1st Nov 201811:43 amRNSNominated Adviser Status
1st Nov 20187:00 amRNSDirector/PDMR Shareholding
31st Oct 20187:00 amRNSDirector/PDMR Shareholding
30th Oct 20184:02 pmRNSDirector/PDMR Shareholding
30th Oct 201810:01 amRNSFunding Closed
30th Oct 20188:01 amRNSCapital raise, board, name change,strategic update
22nd Oct 201810:19 amRNSHolding(s) in Company
2nd Oct 20187:00 amRNSQuarterly update
14th Sep 20181:12 pmRNSDirector/PDMR Shareholding
14th Sep 20189:30 amRNSDirector/PDMR Shareholding
13th Sep 201810:37 amRNSDirector/PDMR Shareholding
13th Sep 20189:32 amRNSDirector/PDMR Shareholding
12th Sep 20189:13 amRNSDirector/PDMR Shareholding
11th Sep 20182:57 pmRNSDirector/PDMR Shareholding
11th Sep 201811:01 amRNSDirector/PDMR Shareholding
10th Sep 20181:52 pmRNSDirector/PDMR Shareholding
5th Sep 201811:02 amRNSDirector/PDMR Shareholding
4th Sep 20183:41 pmRNSDirector/PDMR Shareholding
3rd Sep 20184:43 pmRNSHalf-year Report
29th Aug 20189:21 amRNSHolding(s) in Company
26th Jul 20184:10 pmRNSDirector/PDMR Shareholding
23rd Jul 201811:32 amRNSDirector/PDMR Shareholding
23rd Jul 201810:27 amRNSDirector/PDMR Shareholding
23rd Jul 201810:08 amRNSHolding(s) in Company
18th Jul 20185:05 pmRNSHolding(s) in Company
16th Jul 20189:19 amRNSDirector/PDMR Shareholding Amendment
13th Jul 20182:36 pmRNSHolding(s) in Company
13th Jul 20182:09 pmRNSDirector/PDMR Shareholding
11th Jul 201810:12 amRNSDirector/PDMR Shareholding
9th Jul 20182:18 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.